New Imaging Guidelines for Nuclear Cardiology Procedures
A new guideline published this month by the American Society of Nuclear Cardiology (ASNC) provides practicing nuclear cardiologists, electronic healthcare records, standards writers, and...
Study highlights benefits of using endometrial stem cells to restore functioning of brain cells
Stem cells derived from the endometrium (uterine lining) and transplanted into the brains of laboratory mice with Parkinson's disease appear to restore functioning ofbrain...
Medtronic CEO and chairman Omar Ishrak to make a formal presentation on the company...
Medtronic plc , the global leader in medical technology announced it will participate in the CECP CEO Investor Forum 3.0 in New York on...
ContraVir Pharma to advance second-gen formulation of Tenofovir Exalidex
ContraVir Pharmaceuticals, Inc. a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced it is developing a second-generation formulation of...
Preliminary Data from Study Demonstrates 94% Accuracy in Detecting Aggressive Prostate Cancer
VolitionRx Limited announced preliminary data from a prospective, multi-centered Proof of Concept Study of 84 men into the utility of Volition's Nu.Q™ assays to...
St. Elizabeth Healthcare Partners with CTI and Pulmotect Becoming First Hospital Site for Phase-2...
St. Elizabeth Healthcare has been selected as the first site of the FDA-approved Phase-2 COVID-19 clinical trial studying the drug PUL-042 of Pulmotect, Inc.,...
The University of Virginia Health System and Premier Inc Create Strategic Partnership
The University of Virginia Health System (UVA), a 600-bed academic medical center serving the Commonwealth, Mid-Atlantic and beyond, has signed a multi-year agreement with...
Vomaris Technology Impacts Biofilm-Induced Antibiotic Resistance
Vomaris Innovations, Inc. announced a notable presentation of clinically relevant data on how exposure to electric fields generated by their Advanced Microcurrent Technology® disrupts...
Imminence of New Gonorrhea Therapeutic Drugs is Evident as the Bacteria Grow Super Resistant...
According to a new study, the gonorrhea therapeutics market will reach US$ 970 Mn in 2019, and estimated to register a 4% Y-o-Y over...
New Research System Finds & Targets Vulnerabilities in Lung Cancer Cells
Genetic changes that help lung cancer thrive also make it vulnerable to a promising experimental drug, according to a study led by researchers from...
